Announced Sat, 30 May · 19:22 IST

The Company hereby submits Outcome of Board Meeting held on today i.e. 30.05.2026

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-12.9%1-day move

₹183.80

prior close

₹181.20

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.7-0.7+2.1-6.2-12.9-16.6-12.9-17.3-17.3-20.0-12.6-12.9——

Up moveDown movePending

AI summary

Simran Farms Limited's Board approved Standalone and Consolidated Audited Financial Results for Q4 and financial year ended 31st March 2026. Standalone total revenue for FY26 was Rs. 8,771.33 lakh, with net profit of Rs. 494.55 lakh (vs Rs. 579.50 lakh in FY25, showing a decline). Basic EPS stands at Rs. 13.02 per share. The company declared an unmodified audit opinion with no qualifications from statutory auditors Khandelwal Kakani & Co. The Board meeting was held on 30th May 2026 from 4:00 PM to 6:30 PM. Consolidated results include subsidiary Puregene Biotech Limited. Cash and cash equivalents at year end were Rs. 115.95 lakh (standalone).

Likely market impact

The company reported lower profit compared to previous year (net profit down ~15% YoY), but maintained clean audit status with unmodified opinion, which is a positive signal for investor confidence despite the profit decline.